Trial Profile
Phase II study of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma. Compared with retrospective historical cohort study with epirubicin hydrochloride.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 15 Mar 2011 New trial record